menu

Biosimilars

Biosimilar development and commercialization is a uniquely difficult endeavor requiring precise, stepwise planning to ensure timely regulatory approval and optimal market access.

Nigel Rulewski
Featured
Nigel Rulewski discusses the first approval of a biosimilar in the United States.

Quintiles Blog

Fresh ideas and insights from our experts around the globe

Blog

Quintiles Authors

Vice President, Global Strategic Drug Development and Head of Quintiles Global Biosimilars Unit

Executive Director, Global Strategic Drug Development and Head of Global Biosimilars Strategic Planning

Peer-Reviewed Publications